120 related articles for article (PubMed ID: 12038453)
1. Prevalence and clinical significance of anticardiolipin and anti-beta2-glycoprotein-I antibodies in patients with non-Hodgkin's lymphoma.
Genvresse I; Lüftner D; Späth-Schwalbe E; Buttgereit F
Eur J Haematol; 2002 Feb; 68(2):84-90. PubMed ID: 12038453
[TBL] [Abstract][Full Text] [Related]
2. Antiphospholipid antibodies may be a new prognostic parameter in aggressive non-Hodgkin's lymphoma.
Bairey O; Blickstein D; Monselise Y; Lahav J; Stark P; Prokocimer M; Nativ HM; Kirgner I; Pazgal I; Shaklai M
Eur J Haematol; 2006 May; 76(5):384-91. PubMed ID: 16466368
[TBL] [Abstract][Full Text] [Related]
3. Arterial thrombosis associated with anticardiolipin and anti-beta2-glycoprotein-I antibodies in patients with non-Hodgkin's lymphoma: a report of two cases.
Genvresse I; Buttgereit F; Späth-Schwalbe E; Ziemer S; Eucker J; Possinger K
Eur J Haematol; 2000 Nov; 65(5):344-7. PubMed ID: 11092466
[TBL] [Abstract][Full Text] [Related]
4. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.
Bertolaccini ML; Atsumi T; Escudero Contreras A; Khamashta MA; Hughes GR
J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209
[TBL] [Abstract][Full Text] [Related]
5. Serum anti-beta2-glycoprotein-I and anticardiolipin antibodies during thrombosis in systemic lupus erythematosus patients.
Gómez-Pacheco L; Villa AR; Drenkard C; Cabiedes J; Cabral AR; Alarcón-Segovia D
Am J Med; 1999 Apr; 106(4):417-23. PubMed ID: 10225244
[TBL] [Abstract][Full Text] [Related]
6. IgG anti-beta2-glycoprotein I antibodies in adult patients with systemic lupus erythematosus: prevalence and diagnostic value for the antiphospholipid syndrome.
Tubach F; Hayem G; Marchand JL; Weber M; Palazzo E; de Bandt M; Roux S; Kahn MF; Meyer O
J Rheumatol; 2000 Jun; 27(6):1437-43. PubMed ID: 10852267
[TBL] [Abstract][Full Text] [Related]
7. IgG and IgM isotypes of anti-cardiolipin and anti-beta2-glycoprotein i antibodies reflect different forms of recent thrombo-embolic events.
Locht H; Wiik A
Clin Rheumatol; 2006 Mar; 25(2):246-50. PubMed ID: 16177835
[TBL] [Abstract][Full Text] [Related]
8. IgG reactivity to phospholipid-bound beta(2)-glycoprotein I is the main determinant of the fraction of lupus anticoagulant activity quenched by addition of hexagonal (II) phase phospholipid in patients with the clinical suspicion of antiphospholipid-antibody syndrome.
Safa O; Crippa L; Della Valle P; Sabbadini MG; Viganò D'Angelo S; D'Angelo A
Haematologica; 1999 Sep; 84(9):829-38. PubMed ID: 10477458
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of antibodies to beta2-glycoprotein I in systemic lupus erythematosus and their association with antiphospholipid antibody syndrome criteria: a single center study and literature review.
Bruce IN; Clark-Soloninka CA; Spitzer KA; Gladman DD; Urowitz MB; Laskin CA
J Rheumatol; 2000 Dec; 27(12):2833-7. PubMed ID: 11128672
[TBL] [Abstract][Full Text] [Related]
10. High titres of IgM-antiphospholipid antibodies are unrelated to pathogenicity in patients with non-Hodgkin's lymphoma.
Miesbach W; Scharrer I; Asherson RA
Clin Rheumatol; 2007 Jan; 26(1):95-7. PubMed ID: 16721493
[TBL] [Abstract][Full Text] [Related]
11. Thromboembolic risk in patients with high titre anticardiolipin and multiple antiphospholipid antibodies.
Neville C; Rauch J; Kassis J; Chang ER; Joseph L; Le Comte M; Fortin PR
Thromb Haemost; 2003 Jul; 90(1):108-15. PubMed ID: 12876633
[TBL] [Abstract][Full Text] [Related]
12. Clinical significance of anticardiolipin and anti-beta2-glycoprotein I antibodies.
Obermoser G; Bitterlich W; Kunz F; Sepp NT
Int Arch Allergy Immunol; 2004 Oct; 135(2):148-53. PubMed ID: 15345914
[TBL] [Abstract][Full Text] [Related]
13. Prevalence and clinical associations of lupus anticoagulant, anticardiolipin antibodies, and anti-beta2-glycoprotein I antibodies in patients with systemic lupus erythematosus.
Woo KS; Kim KE; Kim JM; Han JY; Chung WT; Kim KH
Korean J Lab Med; 2010 Feb; 30(1):38-44. PubMed ID: 20197721
[TBL] [Abstract][Full Text] [Related]
14. Anti-beta2-glycoprotein I antibodies in women with recurrent spontaneous abortion, unexplained fetal death, and antiphospholipid syndrome.
Lee RM; Emlen W; Scott JR; Branch DW; Silver RM
Am J Obstet Gynecol; 1999 Sep; 181(3):642-8. PubMed ID: 10486478
[TBL] [Abstract][Full Text] [Related]
15. Clinical significance of antiphospholipid protein antibodies. Receiver operating characteristics plot analysis.
Musial J; Swadzba J; Motyl A; Iwaniec T
J Rheumatol; 2003 Apr; 30(4):723-30. PubMed ID: 12672190
[TBL] [Abstract][Full Text] [Related]
16. Antibody profiles for the diagnosis of antiphospholipid syndrome.
Pengo V; Biasiolo A; Pegoraro C; Cucchini U; Noventa F; Iliceto S
Thromb Haemost; 2005 Jun; 93(6):1147-52. PubMed ID: 15968401
[TBL] [Abstract][Full Text] [Related]
17. High frequency of abnormal levels of IgA anti-beta2-glycoprotein I antibodies in patients with systemic lupus erythematosus: relationship with antiphospholipid syndrome.
Fanopoulos D; Teodorescu MR; Varga J; Teodorescu M
J Rheumatol; 1998 Apr; 25(4):675-80. PubMed ID: 9558168
[TBL] [Abstract][Full Text] [Related]
18. Antibodies to age-β2 glycoprotein I in patients with anti-phospholipid antibody syndrome.
Sorice M; Buttari B; Capozzi A; Profumo E; Facchiano F; Truglia S; Recalchi S; Alessandri C; Conti F; Misasi R; Valesini G; Riganò R
Clin Exp Immunol; 2016 May; 184(2):174-82. PubMed ID: 26702877
[TBL] [Abstract][Full Text] [Related]
19. Isotype distribution and clinical significance of antibodies to cardiolipin, phosphatidic acid, phosphatidylinositol and phosphatidylserine in systemic lupus erythematosus: prospective analysis of a series of 92 patients.
López-Soto A; Cervera R; Font J; Bové A; Reverter JC; Muñoz FJ; Miret C; Espinosa G; Ordinas A; Ingelmo M
Clin Exp Rheumatol; 1997; 15(2):143-9. PubMed ID: 9196865
[TBL] [Abstract][Full Text] [Related]
20. Increased levels of beta 2 glycoprotein-I antigen and beta 2 glycoprotein-I binding antibodies are associated with a history of thromboembolic complications in patients with SLE and primary antiphospholipid syndrome.
McNally T; Mackie IJ; Machin SJ; Isenberg DA
Br J Rheumatol; 1995 Nov; 34(11):1031-6. PubMed ID: 8542203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]